Pharmaceutical Cold Chain Packaging Market

Pharmaceutical cold chain packaging sales will rise through 2036, driven by passive packaging at 72.5% share of the packaging type segment in 2026. Pharmaceutical and biopharma companies account for 52.8% of end-use demand. The market was valued at USD 21.2 billion in 2026 and is likely to expand to USD 95.8 billion by 2036.